ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,206Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 1006

$743K Total Retail Price of All Prescriptions

Rank: 95 out of 1006

462 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 11,380 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 587 525 1 3
AMLODIPINE BESYLATE 545 503 2 4
LEVOTHYROXINE SODIUM 424 381 3 2
FUROSEMIDE 389 383 4 6
ATORVASTATIN CALCIUM 356 346 5 5
SIMVASTATIN 349 329 6 1
HYDROCHLOROTHIAZIDE 300 272 7 11
METOPROLOL TARTRATE 290 281 8 7
NAMENDA 263 263 9 34
METOPROLOL SUCCINATE 242 218 10 12
WARFARIN SODIUM 229 229 11 8
CRESTOR 194 185 12 18
OMEPRAZOLE 193 189 13 9
GLYBURIDE 186 172 R 14 65
DONEPEZIL HCL 183 183 15 17
HYDROCODONE-ACETAMINOPHEN 175 169 S3 16 25
ZOLPIDEM TARTRATE 171 135 17 14
METFORMIN HCL 164 156 18 10
LOSARTAN POTASSIUM 150 150 19 22
FLUOXETINE HCL 130 130 20 85
ALENDRONATE SODIUM 122 117 21 29
ATENOLOL 115 115 22 13
KLOR-CON M20 114 112 23 70
QUINAPRIL HCL 111 111 24 86
TRAMADOL HCL 110 106 25 35
CITALOPRAM HBR 108 105 26 24
DOXAZOSIN MESYLATE 103 103 27 87
GABAPENTIN 99 78 28 20
ALLOPURINOL 96 95 29 31
SPIRIVA 91 88 30 48
ESCITALOPRAM OXALATE 90 87 31 27
EXELON 89 89 32 99
POTASSIUM CHLORIDE 89 82 32 30
FLUTICASONE PROPIONATE 88 74 34 55
ZETIA 86 82 35 51
TAMSULOSIN HCL 85 85 36 23
PRAVASTATIN SODIUM 84 84 37 15
PANTOPRAZOLE SODIUM 84 77 37 32
DIOVAN 81 72 39 16
BENICAR 81 81 39 78
SPIRONOLACTONE 81 60 39 71
MIRTAZAPINE 78 76 42 26
VENLAFAXINE HCL ER 75 75 43 105
LOVASTATIN 74 74 44 44
FINASTERIDE 73 73 45 76
RANITIDINE HCL 72 72 46 63
DIGOXIN 71 71 47 52
SERTRALINE HCL 66 66 48 19
ISOSORBIDE MONONITRATE ER 65 65 49 59
PREDNISONE 65 63 49 33
CARBIDOPA-LEVODOPA 61 61 51 80
TRAZODONE HCL 59 48 52 21
CYMBALTA 59 39 52 41
BUPROPION HCL SR 58 58 54 174
BYSTOLIC 58 57 54 84
DILTIAZEM 24HR CD 57 57 56 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 44 57 38
QUETIAPINE FUMARATE 54 54 58 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.